In the latest reporting period of Q4'26, the total operating expenses reached approximately 11.89B USD, comprising 2.74B USD in R&D Expenses and 9.15B USD in SG&A Expenses. This data point represents a significant decrease compared to the previous quarter, Q3'26, where the total expenditure peaked at 95.77B USD. From Q1'24 to Q3'26, the company experienced a consistent upward trend in total operating expenses, driven primarily by a substantial rise in SG&A Expenses which grew from 34.34B USD to 80.29B USD. While R&D Expenses remained relatively stable between 10B USD and 17B USD during this timeframe, SG&A consistently represented the dominant portion of the expenditure mix. The overall trend reflects a period of aggressive spending that peaked in Q2'26 and Q3'26 before the sharp decline observed in Q4'26.